Please try another search
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.
Name | Age | Since | Title |
---|---|---|---|
Robert Bain Thomas | 78 | 2012 | Independent & Non-Executive Director |
Stephen Alister Locarnini | - | 2018 | Independent & Non-Executive Director |
Michael John Hoy | 74 | 2000 | Independent Non Executive Chairman |
Michelle Miller | - | 2002 | MD & Executive Director |
Susan Margaret Pond | - | 2012 | Independent & Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review